You are here: Home » News-CM » Companies » Results
Business Standard

Bharat Immunological & Biological Corporation reports standalone net loss of Rs 2.24 crore in the March 2019 quarter

Capital Market 

Sales rise 225.69% to Rs 70.61 crore

Net Loss of reported to Rs 2.24 crore in the quarter ended March 2019 as against net loss of Rs 1.31 crore during the previous quarter ended March 2018. Sales rose 225.69% to Rs 70.61 crore in the quarter ended March 2019 as against Rs 21.68 crore during the previous quarter ended March 2018.

For the full year,net loss reported to Rs 5.56 crore in the year ended March 2019 as against net loss of Rs 4.26 crore during the previous year ended March 2018. Sales rose 140.37% to Rs 83.65 crore in the year ended March 2019 as against Rs 34.80 crore during the previous year ended March 2018.

ParticularsQuarter EndedYear EndedMar. 2019Mar. 2018% Var.Mar. 2019Mar. 2018% Var.Sales70.6121.68 226 83.6534.80 140 OPM %-6.12-19.79 --10.68-23.59 - PBDT-3.16-4.05 22 -7.78-7.55 -3 PBT-3.13-4.10 24 -8.06-7.96 -1 NP-2.24-1.31 -71 -5.56-4.26 -31

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, April 13 2019. 08:16 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU